---
title: "Advancing Heart Failure (TEAM-HF) | Sutter Health"
description: "Trial to Evaluate Safety and Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure"
url: "https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Clinical trials](https://www.sutterhealth.org/research/clinical-trials) /
4.  Advancing Heart Failure (TEAM-HF)

# Heart Failure - TEAM-HF

**Status:** Open to Enrollment

[Email us to enroll](https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574#enroll)

#### Study details

View study details on [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06526195?term=nct06526195&rank=1).

#### Locations

-   Sacramento

#### Clinical trial FAQs

Information for patients and study volunteers, including [frequently asked questions](https://www.sutterhealth.org/research/faqs).

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

![Michael A Gibson, M.D.](https://dyn.mktgcdn.com/p/NolUewmoUYddS_gYCTjeXSfuNvNfdSw9k8n9Er31_Bg/fit=crop,gravity=auto,dpr=2,width=188,height=250,quality=100)

Michael A Gibson, M.D.

Principal investigator

[View profile](https://www.sutterhealth.org/research/investigators/michael-a-gibson-md-1097247582)

## Sub-Investigators

[Gurpreet S Sodhi, M.D.](https://www.sutterhealth.org/research/investigators/gurpreet-s-sodhi-md-1049681244) , [Zijian Xu, M.D., Ph.D., FACC](https://www.sutterhealth.org/research/investigators/zijian-xu-md-phd-facc-1049681028)

## Email us to enroll

-   [Email Sacramento](mailto:ClinicalResearch%40sutterhealth.org?subject=More%20information%20on%20Heart%20Failure%20-%20TEAM-HF%20in%20Sacramento&body=Please%20be%20aware%20that%20if%20you%20reply%20with%20unencrypted%20email%2C%20this%20increases%20the%20risk%20that%20information%20could%20be%20read%20by%20an%20unauthorized%20third%20party.%20Please%20do%20not%20include%20any%20Protected%20Health%20Information%20in%20your%20email%20response.)

## Related clinical trials

[View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial)

-   Clinical trial
    
    ### [Heart Failure COMET-HF](https://www.sutterhealth.org/research/clinical-trials/heart-failure-comet-hf-2015330118)
    
    A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients With Symptomatic Heart Failure With Severely Reduced Ejection Fraction (COMET-HF)
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Heart Failure CONFIRMATION-HF](https://www.sutterhealth.org/research/clinical-trials/heart-failure-confirmation-hf-1095250414)
    
    Combined Efficacy and Safety of an Early, Intensive, Management Strategy with Finerenone and SGLT2 Inhibitor in Patients Hospitalized with Heart Failure (CONFIRMATION-HF)
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Heart Failure FINALITY-HF](https://www.sutterhealth.org/research/clinical-trials/heart-failure-finality-hf-2005599814)
    
    A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Heart Failure REDEFINE-HF](https://www.sutterhealth.org/research/clinical-trials/heart-failure-redefine-hf-1095250384)
    
    Randomized Trial to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Heart Failure Patients With Left Ventricular Ejection Fraction Greater Than or Equal to 40% Hospitalized Due to an Episode of Acute Decompensated Heart Failure (REDEFINE-HF)
    
    **Status:** Open to Enrollment
    
-   Clinical trial
    
    ### [Heart Failure AIM HIGHer Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System CA\_CP\_340](https://www.sutterhealth.org/research/clinical-trials/heart-failure-aim-higher-cardiac-contractility-modulation-therapy-via-optimizer-smart-mini-system-ca_cp_340-2077445142)
    
    Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction
    
    **Status:** Open to Enrollment
    

[View all clinical trials](https://www.sutterhealth.org/research-search-results?verticalKey=clinical_trial)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Clinical trials","item":"https://www.sutterhealth.org/research/clinical-trials"},{"@type":"ListItem","position":4,"name":"Advancing Heart Failure (TEAM-HF)"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574#medicalwebpage","name":"Heart Failure - TEAM-HF","description":"Trial to Evaluate Safety and Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure","url":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574","inLanguage":"en-US","dateModified":"2026-06-01","publisher":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"},"medicalAudience":{"@type":"MedicalAudience","audienceType":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574#medicaltrial"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574#breadcrumblist"},"mentions":[{"@type":"Person","name":"Michael A Gibson, M.D.","url":"https://www.sutterhealth.org/research/investigators/michael-a-gibson-md-1097247582","jobTitle":"Principal Investigator","affiliation":{"@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org"}}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalTrial","@id":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574#medicaltrial","name":"Heart Failure - TEAM-HF","alternateName":"Trial to Evaluate Safety and Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure","url":"https://www.sutterhealth.org/research/clinical-trials/advancing-heart-failure-team-hf-1097247574","description":"The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.","identifier":"NCT06526195","code":{"@type":"MedicalCode","codeValue":"NCT06526195","codingSystem":"ClinicalTrials.gov"},"sameAs":"https://clinicaltrials.gov/study/NCT06526195?term=nct06526195&rank=1","status":"https://schema.org/Recruiting","healthCondition":[{"@type":"MedicalCondition","name":"Heart Failure"}],"studyLocation":[{"@type":"AdministrativeArea","name":"Sacramento"}]}
```
